Service Hotline +86 400-068-7188
Service Hotline +86 400-068-7188
Chinese Patent Medicines Industry Production & Marketing Demand and Investment Forecast Report, 2013-2017
A must-have for enterprise medium to long-term strategic planning
Without deep industry knowledge, it will be difficult to gain any return
English Version：USD7900
Including: Paper back + Electronic Copy + Invoice
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188After-sales Hotline： +86 755-33013088
The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188
0755 - 82925195
400-068-7188
We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product.
Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase.
Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the"
"trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!
* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!
Table of Contents
Content Summary
Chapter 1: Development Overview of Chinese Patent Medicines Industry
1.1 Definition and Classification of Chinese Patent Medicines Industry
1.1.1 Industry Concept and Definition
1.1.2 Main Industry Product Categories
1.1.3 Types of TCM (Traditional Chinese Medicine) Protected Catalogue
1.2 Importance of Chinese Patent Medicines Industry
1.2.1 Industry Position in Pharmaceutical Industry
1.2.2 Industry Position in National Economy
1.3 Analysis of Industrial Chain of Chinese Patent Medicines Industry
1.3.1 Analysis of Industrial Chain of Chinese Patent Medicines Industry
1.3.2 Analysis of Main Upstream Industrial Chain of Chinese Patent Medicines Industry
(1) Development Analysis of Medical Planting Industry
(2) Analysis of Chinese Herbal Medicine Market Quotation
(3) Development Analysis of Chinese Herbal Pieces Industry
(4) Development Analysis of Plant Extract Industry
1.3.3 Analysis of Sales Terminal of Chinese Patent Medicines Industry
(1) Development Status and Trend of Hospital Terminal
(2) Development Status and Trend of Drugstore Terminal
(3) Development Status and Trend of Third-party Terminal
1.4 Industry Research Methods and Data Statistical Standards
1.4.1 Overview of Industry Research Methods
1.4.2 Industry Data Sources
1.4.3 Industry Data Statistical Standards
Chapter 2: Development Operation Overview of China Chinese Patent Medicines Industry
2.1 TCM Development Status and Strategies
2.1.1 TCM Development Status
2.1.2 TCM Development Problems
2.1.3 Strategies for Promoting TCM Development
2.2 Analysis of Development Conditions of Chinese Patent Medicines Industry
2.2.1 Overall Development Information of Chinese Patent Medicines Industry
2.2.2 Main Development Features of Chinese Patent Medicines Industry
2.2.3 Operation Analysis of Chinese Patent Medicines Industry, 2010-2011
(1) Analysis of Operation Benefit of Chinese Patent Medicines Industry, 2010-2011
(2) Analysis of Profitability of Chinese Patent Medicines Industry, 2010-2011
(3) Analysis of Operation Capability of Chinese Patent Medicines Industry, 2010-2011
(4) Analysis of Debt-paying Ability of Chinese Patent Medicines Industry, 2010-2011
(5) Analysis of Development Capability of Chinese Patent Medicines Industry, 2010-2011
2.3 Analysis of Economic Indicators of Chinese Patent Medicines Industry
2.3.1 Main Economic Benefit Influencing Factors to Chinese Patent Medicines Industry
2.3.2 Analysis of Economic Indicators of Chinese Patent Medicines Industry, 2010-2011
2.3.3 Analysis of Economic Indicators of Enterprises with Different Scales, 2010-2011
2.3.4 Analysis of Economic Indicators of Enterprises with Different Economic Properties, 2010-2011
2.3.5 Analysis of Economic Indicators of Enterprises in Different Regions, 2010-2011
2.4 Analysis of Supply and Demand Balance of Chinese Patent Medicines Industry
2.4.1 Analysis of Supply Conditions of National Chinese Patent Medicines Industry, 2010-2011
(1) Analysis of Total Industrial Output Value of National Chinese Patent Medicines Industry, 2010-2011
(2) Analysis of Finished Products of National Chinese Patent Medicines Industry, 2010-2011
2.4.2 Analysis of Supply Conditions of Regional Chinese Patent Medicines Industry, 2010-2011
(1) Analysis of Top 10 Regions with Highest Total Industrial Output Value, 2010-2011
(2) Analysis of Top Regions with Most Finished Products, 2010-2011
2.4.3 Analysis of Demand Conditions of National Chinese Patent Medicines Industry, 2010-2011
(1) Analysis of Sales Value of National Chinese Patent Medicines Industry
(2) Analysis of Sales Revenue of National Chinese Patent Medicines Industry
2.4.4 Analysis of Demand Conditions of Regional Chinese Patent Medicines Industry, 2010-2011
(1) Analysis of Top 10 Regions with Highest Sales Value
(2) Analysis of Top Regions with Highest Sales Revenue
2.4.5 Analysis of Production and Marketing Rate of National Chinese Patent Medicines Industry
Chapter 3: Analysis of Chinese Patent Medicines Industry Market Environment
3.1 Analysis of Industry Policy Environment
3.1.1 Competent Departments and Management Mechanism in Industry
3.1.2 Policy Trends Related to Industry
(1) New Measures for Drug GMP Certification
(2) Drug Price Control Measures
(3) Notice on Printing and Issuing Protective Principles for Chinese Medicine Catalogue
(4) Opinions of State Council on Supporting and Accelerating Development of Traditional Chinese Medicines
(5) Medium and Long-term Outline for International Exchange and Cooperation of Traditional Chinese Medicine
3.1.3 Industry Development Planning
3.2 Analysis of Industry Economic Environment
3.2.1 Analysis of Domestic Macro-economic Environment
(1) China’s GDP Growth
(2) Resident Per Capital GDP Growth
(3) Resident Income Growth
(4) Resident Consumption Expense Level
(5) Analysis of Resident Consumption Structure
3.2.2 Analysis of Industry Macro-economic Environment
3.3 Analysis of Industry Demand Environment
3.3.1 Total Population Growth
3.3.2 Population Structure Changes
(1) Population Aging Trend
(2) Urbanization Progress
3.3.3 Resident Medical Healthcare Level
3.4 Analysis of Industry Social Environment
3.4.1 Coordination between Industry Development and Social Economy
3.4.2 Regional Unbalanced Problems in Industry Development
3.5 Industry Quality and Safety Environment
3.5.1 Impact of GMP Certification on Chinese Patent Medicines Development
3.5.2 Analysis of Industry Quality and Safety Environment Trend
Chapter 4: Analysis of Competition Conditions of Chinese Patent Medicines Industry
4.1 Analysis of Overall Industry Market Competition
4.2 Analysis of Industry International Market Competition
4.2.1 Development of International Chinese Patent Medicines Market
4.2.2 Analysis of Competition of International Chinese Patent Medicines Market
4.2.3 Analysis of Development Trend of Chinese Patent Medicines Market
4.2.4 Multinationals’ Investment Layout in China’s Market
4.2.5 Analysis of Multinationals’ Competition Strategies in China
4.3 Analysis of Market Operation of Domestic Chinese Patent Medicines Industry
4.4 Analysis of Industry Investment, Merger and Restructuring Integration
4.4.1 Overview of Chinese Patent Medicines Industry Investment, Merger and Restructuring Integration
4.4.2 Investment, Merger and Restructuring Integration of International Chinese Patent Medicines Market
4.4.3 Investment, Merger and Restructuring Integration of Domestic Chinese Patent Medicines Market
4.4.4 Features Judgment of Chinese Patent Medicines Industry Investment, Merger and Restructuring Integration
4.5 Features Analysis of Enterprises with Different Economic Properties in Industry
4.5.1 Features Conditions of Enterprises with Different Economic Properties
4.5.2 Concentration Analysis of Industry Economic Properties
Chapter 5: Analysis of Main Product Markets in Chinese Patent Medicines Industry
5.1 Main Product Structure Features in Industry
5.1.1 Analysis of Product Structure Features in Industry
5.1.2 Development Overview of Industry Product Markets
5.2 Analysis of Main Product Markets in Industry
5.2.1 Analysis of Chinese Patent Medicines Market for Cardiovascular
(1) Market Scale of Chinese Patent Medicines for Cardiovascular
(2) Market Competition of Chinese Patent Medicines for Cardiovascular
(3) Market Prospects of Chinese Patent Medicines for Cardiovascular
5.2.2 Analysis of Chinese Patent Medicines Market for Anti-tumor
(1) Market Scale of Chinese Patent Medicines for Anti-tumor
(2) Market Competition of Chinese Patent Medicines for Anti-tumor
(3) Market Prospects of Chinese Patent Medicines for Anti-tumor
5.2.3 Analysis of Chinese Patent Medicines Market for Respiratory System
(1) Hospital Market of Chinese Patent Medicines for Respiratory System
(2) Product Catalogue of Chinese Patent Medicines for Respiratory System
(3) Competitive Landscape of Chinese Patent Medicines for Respiratory System
1) Analysis of Market Competition of Chinese Patent Medicines for Respiratory System
2) Market Segments Competition of Chinese Patent Medicines for Respiratory System
1. Market Competition of Clearing Heat and Removing Toxicity Preparations
2. Market Competition of Cough, Expectorant and Anti-Asthma Preparations
3. Market Competition of Cold Preparations
4. Market Competition of Throat Preparations
5.2.4 Analysis of Chinese Patent Medicines Market for Musculo-Skeletal
(1) Product Catalogue of Chinese Patent Medicines for Musculo-Skeletal
(2) Market Competition of Chinese Patent Medicines for Musculo-Skeletal
(3) Market Prospects of Chinese Patent Medicines for Musculo-Skeletal
5.2.5 Analysis of Chinese Patent Medicines Market for Digestive System
(1) Market Scale of Chinese Patent Medicines for Digestive System
(2) Market Competition of Chinese Patent Medicines for Digestive System
(3) Market Prospects of Chinese Patent Medicines for Digestive System
5.2.6 Analysis of Chinese Patent Medicines Market for Gynecology
(1) Market Scale of Chinese Patent Medicines for Gynecology
(2) Market Competition of Chinese Patent Medicines for Gynecology
(3) Market Prospects of Chinese Patent Medicines for Gynecology
5.2.7 Analysis of Chinese Patent Medicines Market for Urinary System
(1) Market Scale of Chinese Patent Medicines for Urinary System
(2) Market Competition of Chinese Patent Medicines for Urinary System
(3) Market Prospects of Chinese Patent Medicines for Urinary System
5.2.8 Analysis of Chinese Patent Medicines Market for Nervous System
(1) Market Scale of Chinese Patent Medicines for Nervous System
(2) Market Competition of Chinese Patent Medicines for Nervous System
(3) Market Prospects of Chinese Patent Medicines for Gynecology
5.2.9 Analysis of Chinese Patent Medicines Market for Ophthalmology and Otorhinolaryngology
(1) Market Scale of Chinese Patent Medicines for Ophthalmology and Otorhinolaryngology
(2) Market Competition of Chinese Patent Medicines for Ophthalmology and Otorhinolaryngology
(3) Market Prospects of Chinese Patent Medicines for Ophthalmology and Otorhinolaryngology
5.2.10 Analysis of Chinese Patent Medicines Market for Dermatology
(1) Market Scale of Chinese Patent Medicines for Dermatology
(2) Market Competition of Chinese Patent Medicines for Dermatology
(3) Market Prospects of Chinese Patent Medicines for Dermatology
5.2.11 Analysis of Chinese Patent Medicines Market for Haematinics
(1) Market Scale of Chinese Patent Medicines for Haematinics
(2) Market Competition of Chinese Patent Medicines for Haematinics
(3) Market Prospects of Chinese Patent Medicines for Haematinics
5.3 Main Products Sales Channels and Strategies in Industry
5.3.1 Main Problems in Products Sales Channels of Industry
5.3.2 Development Trends and Strategies of Industry Products Sales Channels
Chapter 6: Analysis of Key Regional Markets in Chinese Patent Medicines Industry
6.1 Features Analysis of Overall Industry Regional Structure
6.1.1 Overall Features of Industry Regional Structure
6.1.2 Analysis of Industry Regional Concentration
6.1.3 Analysis of Industry Regional Distribution Features
6.1.4 Analysis of Regional Distribution of Industry Scale Indicators
6.1.5 Analysis of Regional Distribution of Industry Benefit Indicators
6.1.6 Analysis of Regional Distribution of Industry Enterprise Quantity
6.2 Development Analysis and Forecast for Jilin Chinese Patent Medicines Industry
6.2.1 Development Planning and Supporting Measures of Jilin Chinese Patent Medicines Industry
6.2.2 Position Changes of Jilin Chinese Patent Medicines Industry
6.2.3 Analysis of Economic Operation of Jilin Chinese Patent Medicines Industry
6.2.4 Enterprises Analysis of Jilin Chinese Patent Medicines Industry
6.2.5 Development Trend Forecast for Jilin Chinese Patent Medicines Industry
6.3 Development Analysis and Forecast for Sichuan Chinese Patent Medicines Industry
6.3.1 Development Planning and Supporting Measures of Sichuan Chinese Patent Medicines Industry
6.3.2 Position Changes of Sichuan Chinese Patent Medicines Industry
6.3.3 Analysis of Economic Operation of Sichuan Chinese Patent Medicines Industry
6.3.4 Enterprises Analysis of Sichuan Chinese Patent Medicines Industry
6.3.5 Development Trend Forecast for Sichuan Chinese Patent Medicines Industry
6.4 Development Analysis and Forecast for Guangdong Chinese Patent Medicines Industry
6.4.1 Development Planning and Supporting Measures of Guangdong Chinese Patent Medicines Industry
6.4.2 Position Changes of Guangdong Chinese Patent Medicines Industry
6.4.3 Analysis of Economic Operation of Guangdong Chinese Patent Medicines Industry
6.4.4 Enterprises Analysis of Guangdong Chinese Patent Medicines Industry
6.4.5 Development Trend Forecast for Guangdong Chinese Patent Medicines Industry
6.5 Development Analysis and Forecast for Guangxi Chinese Patent Medicines Industry
6.5.1 Development Planning and Supporting Measures of Guangxi Chinese Patent Medicines Industry
6.5.2 Position Changes of Guangxi Chinese Patent Medicines Industry
6.5.3 Analysis of Economic Operation of Guangxi Chinese Patent Medicines Industry
6.5.4 Enterprises Analysis of Guangxi Chinese Patent Medicines Industry
6.5.5 Development Trend Forecast for Guangxi Chinese Patent Medicines Industry
6.6 Development Analysis and Forecast for Jiangxi Chinese Patent Medicines Industry
6.6.1 Development Planning and Supporting Measures of Jiangxi Chinese Patent Medicines Industry
6.6.2 Position Changes of Jiangxi Chinese Patent Medicines Industry
6.6.3 Analysis of Economic Operation of Jiangxi Chinese Patent Medicines Industry
6.6.4 Enterprises Analysis of Jiangxi Chinese Patent Medicines Industry
6.6.5 Development Trend Forecast for Jiangxi Chinese Patent Medicines Industry
6.7 Development Analysis and Forecast for Shandong Chinese Patent Medicines Industry
6.7.1 Development Planning and Supporting Measures of Shandong Chinese Patent Medicines Industry
6.7.2 Position Changes of Shandong Chinese Patent Medicines Industry
6.7.3 Analysis of Economic Operation of Shandong Chinese Patent Medicines Industry
6.7.4 Enterprises Analysis of Shandong Chinese Patent Medicines Industry
6.7.5 Development Trend Forecast for Shandong Chinese Patent Medicines Industry
6.8 Development Analysis and Forecast for Guizhou Chinese Patent Medicines Industry
6.8.1 Development Planning and Supporting Measures of Guizhou Chinese Patent Medicines Industry
6.8.2 Position Changes of Guizhou Chinese Patent Medicines Industry
6.8.3 Analysis of Economic Operation of Guizhou Chinese Patent Medicines Industry
6.8.4 Enterprises Analysis of Guizhou Chinese Patent Medicines Industry
6.8.5 Development Trend Forecast for Guizhou Chinese Patent Medicines Industry
6.9 Development Analysis and Forecast for Hubei Chinese Patent Medicines Industry
6.9.1 Development Planning and Supporting Measures of Hubei Chinese Patent Medicines Industry
6.9.2 Position Changes of Hubei Chinese Patent Medicines Industry
6.9.3 Analysis of Economic Operation of Hubei Chinese Patent Medicines Industry
6.9.4 Enterprises Analysis of Hubei Chinese Patent Medicines Industry
6.9.5 Development Trend Forecast for Hubei Chinese Patent Medicines Industry
6.10 Development Analysis and Forecast for Henan Chinese Patent Medicines Industry
6.10.1 Development Planning and Supporting Measures of Henan Chinese Patent Medicines Industry
6.10.2 Position Changes of Henan Chinese Patent Medicines Industry
6.10.3 Analysis of Economic Operation of Henan Chinese Patent Medicines Industry
6.10.4 Enterprises Analysis of Henan Chinese Patent Medicines Industry
6.10.5 Development Trend Forecast for Henan Chinese Patent Medicines Industry
6.11 Development Analysis and Forecast for Hunan Chinese Patent Medicines Industry
6.11.1 Development Planning and Supporting Measures of Hunan Chinese Patent Medicines Industry
6.11.2 Position Changes of Hunan Chinese Patent Medicines Industry
6.11.3 Analysis of Economic Operation of Hunan Chinese Patent Medicines Industry
6.11.4 Enterprises Analysis of Hunan Chinese Patent Medicines Industry
6.11.5 Development Trend Forecast for Hunan Chinese Patent Medicines Industry
6.12 Development Analysis and Forecast for Yunnan Chinese Patent Medicines Industry
6.12.1 Development Planning and Supporting Measures of Yunnan Chinese Patent Medicines Industry
6.12.2 Position Changes of Yunnan Chinese Patent Medicines Industry
6.12.3 Analysis of Economic Operation of Yunnan Chinese Patent Medicines Industry
6.12.4 Enterprises Analysis of Yunnan Chinese Patent Medicines Industry
6.12.5 Development Trend Forecast for Yunnan Chinese Patent Medicines Industry
6.13 Development Analysis and Forecast for Shaanxi Chinese Patent Medicines Industry
6.13.1 Development Planning and Supporting Measures of Shaanxi Chinese Patent Medicines Industry
6.13.2 Position Changes of Shaanxi Chinese Patent Medicines Industry
6.13.3 Analysis of Economic Operation of Shaanxi Chinese Patent Medicines Industry
6.13.4 Enterprises Analysis of Shaanxi Chinese Patent Medicines Industry
6.13.5 Development Trend Forecast for Shaanxi Chinese Patent Medicines Industry
Chapter 7: Analysis of Import and Export Market of Chinese Patent Medicines Industry
7.1 Import and Export Overview of Chinese Patent Medicines Industry
7.2 Analysis of Export Market of Chinese Patent Medicines Industry
7.2.1 Analysis of Industry Export in 2010
(1) Overall Industry Export
(2) Industry Export Product Structure
7.2.2 Analysis of Industry Export in 2011
(1) Overall Industry Export
(2) Industry Export Product Structure
7.3 Analysis of Import Market of Chinese Patent Medicines Industry
7.3.1 Analysis of Industry Import in 2010
(1) Overall Industry Import
(2) Industry Import Product Structure
7.3.2 Analysis of Industry Import in 2011
(1) Overall Industry Import
(2) Industry Import Product Structure
7.4 Import and Export Prospects and Suggestions for Chinese Patent Medicines Industry
7.4.1 Export Prospects and Suggestions for Chinese Patent Medicines Industry
7.4.2 Import Prospects and Suggestions for Chinese Patent Medicines Industry
Chapter 8: Operation Analysis of Leading Enterprises in Chinese Patent Medicines Industry
8.1 Analysis of Overall Development of Chinese Patent Medicines Enterprises
8.1.1 Chinese Patent Medicines Enterprises Scale
8.1.2 Total Industrial Output Value of Chinese Patent Medicines Industry
8.1.3 Sales Income and Profit of Chinese Patent Medicines Industry
8.1.4 Innovation Capability Analysis of Main Chinese Patent Medicines Enterprises
8.2 Case Study of Leading Chinese Patent Medicines Enterprises
8.2.1 Operation Analysis of Jilin Xiuzheng Pharmaceutical Group Co., Ltd.
(1) Analysis of Enterprise Development Profile
(2) Analysis of Enterprise Organization Structure
(3) Analysis of Enterprise Production and Marketing Capability
(4) Analysis of Enterprise Profitability
(5) Analysis of Enterprise Operation Capability
(6) Analysis of Enterprise Debt-paying Ability
(7) Analysis of Enterprise Development Capability
(8) Enterprise Product Structure and New Product Trends
(9) Enterprise Sales Channels and Networks
(10) SWOT Analysis of Enterprise Operational Advantages and Disadvantages
(11) Analysis of Enterprise Investment, Merger and Restructuring
(12) Analysis of Enterprise Latest Development Trend
8.2.2 Operation Analysis of Chongqing Taiji Industry (Group) Co., Ltd.
(1) Analysis of Enterprise Development Profile
(2) Analysis of Enterprise Organization Structure
(3) Analysis of Main Economic Indicators
(4) Analysis of Enterprise Profitability
(5) Analysis of Enterprise Operation Capability
(6) Analysis of Enterprise Debt-paying Ability
With the continuing development of global economy, the modernization of traditional Chinese medicine will face new opportunities and challenges. Since the launch of traditional Chinese medicine modernization in 2007, the supporting efforts of the State has kept increasing. After more than 10 years of development, traditional Chinese medicine modernization in China makes a group of important phased objectives and progress.
As a large country for medicine use, the total size of China medicine market increased from 178.2 billion Yuan in 2011 to the 755.6 billion Yuan in 2010, in the past ten years, with a compound average growth rate of 17.41%. Moreover, it accelerated to develop in 2009 and 2010, with the increase of 20.56% and 29.87% respectively.
In terms of changes of medicine consumption volume, the per capital medicine for Chinese residents increased from 341 Yuan in 2006 to 574 Yuan in 2009, with an annual growth of 19%. However, compared with the per capital medicine of USD 300 in developed countries, there is still a huge gap. Moreover, there is also a large gap between urban and rural places in China. So, the industry has huge space for growth.
With the development of China’s economy and the improvement of people’s living standard, people’s concept of prevention disease has changed, to focus on prevention and healthcare, and prompt adjustment of sub-health status. That is from the “cure illness they suffer” in the past to “cure disease in the future”. The medical care model transfers from simple disease treatment the compound model of prevention, healthcare and recovery as well. Compared with chemical drugs and biological products, Chinese patent medicines are more expert in healing chronic diseases. Chinese patent medicines are suitable for healthcare and aftercare. In terms of health maintenance and healthcare, cardiovascular and cerebrovascular diseases, respiratory system diseases, and other diseases, which need to take medicine for a long time, Chinese patent medicines have more advantages in these fields. Therefore, under the new market concept, Chinese patent medicine will develop very well. The medicine consumption market will be gradually large and the Chinese patent medicine will become a hot spot in medical industry.
As an important link in traditional Chinese medicine, Chinese patent medicines industry is the second main force in China’s pharmaceutical industry, just following chemical drug industry, in terms of enterprise number, industrial total output value, sales revenue and total profit sum. In the internal of the whole pharmaceutical industry, the profitability of Chinese patent medicines is the strongest, with the highest profit ratio. In recent years, the market size keeps growing by more than 19%. And even though during the period of 2008 to 2009, it showed the high prosperity degree.
In 2010, the State clearly defines the biological pharmaceutical industry, including modern Chinese patent medicines into the seven key fields of emerging industries. During the “twelfth five-year” period, the development of Chinese patent medicines industry may mainly focus on the construction of enterprise’s technological platform and technology innovation.
With the continuing development of global economy, the modernization of traditional Chinese medicine will face new opportunities and challenges. Since the launch of traditional Chinese medicine modernization in 2007, the supporting efforts of the State has kept increasing. After more than 10 years of development, traditional Chinese medicine modernization in China makes a group of important phased objectives and progress, in the following aspects: the platform construction of traditional Chinese medicine modernization, the planting and processing technologies research of traditional Chinese medicine’s materials, the common technology research of traditional Chinese medicine, the construction of traditional Chinese medicine bases, the research on traditional Chinese medicine quality standards, etc. As a remarkable result, a group of modern traditional Chinese medicine enterprises spring up, forming a industry system with a certain size; a batch of modern traditional Chinese medicine products have been made. Although there are not too many, the sales volume of simple variety has reached 100 million.
Meanwhile, China’s Patent Office is conducting researches on intellectual property right protection of “increasing the advantages of traditional Chinese medicine”. The investment priorities and hot spots have gradually shifted to traditional Chinese medicine industry. Many local governments have regarded traditional Chinese medicine as local pillar industries, such as Hong Kong, Tianjin, Chengdu, Guizhou, Yunnan, Sichuan, Jilin, etc. The traditional Chinese medicine modernization has vest prospects for development.
Here, we would like to express our sincere gratitude to State Information Center, Bureau of Statistics of China, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report!
Notice: All the market data, especially corporations' ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!
Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Chinese Patent Medicines Industry
The National Bureau of Statistics Foreign-related investigation Permission
National Innovation Company and Dual Software Certified Enterprise
The only DRC desginated Enterprise of the Industry Yearbook
National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation
Guangdong Province Enterprise of Observing Contract and Valuing Credit
Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.
Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.
Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.
Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.
Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.
Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.
Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.
Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.
Free Hotline：+86 400-068-7188
Customer Hotline：+86 755 - 82925195 / 82925295
Email Address：service@qianzhan.com
3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China
Location：Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China
Quality Assured
Offer a forward-looking vision to all of our customers.
Customer Service
We welcome any feedbacks and suggestions to make our customers 100% satisfied.
Qualification Certificates
Having more than 20 qualification certificates, including Innovation Company Certificate and Foreign-related investigation Permission etc.
Customers Testimonials
Thank you for recognizing our high quality products and professional, rigorous and sincere service.
